These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26817583)

  • 1. Are biologics useful for nail psoriasis?
    Antúnez-Lay A; Cabrolier J; Andino-Navarrete R
    Medwave; 2016 Jan; 16 Suppl 1():e6363. PubMed ID: 26817583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secukinumab for plaque psoriasis.
    Ordenes-Cavieres G; Andino-Navarrete R
    Medwave; 2018 Nov; 18(7):e7364. PubMed ID: 30507896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nail Psoriasis: An Updated Review and Expert Opinion on Available Treatments, Including Biologics.
    Bardazzi F; Starace M; Bruni F; Magnano M; Piraccini BM; Alessandrini A
    Acta Derm Venereol; 2019 May; 99(6):516-523. PubMed ID: 30521057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nail psoriasis improvement in a patient treated with fumaric acid esters.
    Vlachou C; Berth-Jones J
    J Dermatolog Treat; 2007; 18(3):175-7. PubMed ID: 17538807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
    Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
    J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacalcitol ointment for the treatment of nail psoriasis.
    Márquez Balbás G; Sánchez Regaña M; Umbert Millet P
    J Dermatolog Treat; 2009; 20(5):308-10. PubMed ID: 19367480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical corticosteroids or vitamin D analogues for plaque psoriasis?
    Venegas-Iribarren S; Andino R
    Medwave; 2017 Jun; 17(Suppl 2):e6981. PubMed ID: 28665918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked improvement in nail psoriasis during treatment with adalimumab.
    Irla N; Yawalkar N
    Dermatology; 2009; 219(4):353-6. PubMed ID: 19851059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis: an evidence-based update. Report of the 9th evidenced based update meeting, 12 May 2011, Loughborough, UK.
    De Mozzi P; Johnston GA; Alexandroff AB
    Br J Dermatol; 2012 Feb; 166(2):252-60. PubMed ID: 22268857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nails: The External Protective Window to the Internal Milieu.
    Sibbald RG; Ayello EA
    Adv Skin Wound Care; 2019 Aug; 32(8):341. PubMed ID: 31335431
    [No Abstract]   [Full Text] [Related]  

  • 11. A 36-week retrospective open trial comparing the efficacy of biological therapies in nail psoriasis.
    Bardazzi F; Antonucci VA; Tengattini V; Odorici G; Balestri R; Patrizi A
    J Dtsch Dermatol Ges; 2013 Nov; 11(11):1065-70. PubMed ID: 24119121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of nail psoriasis: best practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Crowley JJ; Weinberg JM; Wu JJ; Robertson AD; Van Voorhees AS;
    JAMA Dermatol; 2015 Jan; 151(1):87-94. PubMed ID: 25471223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
    Reich K; Burden AD; Eaton JN; Hawkins NS
    Br J Dermatol; 2012 Jan; 166(1):179-88. PubMed ID: 21910698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood nail psoriasis: a useful treatment with tazarotene 0.05%.
    Diluvio L; Campione E; Paternò EJ; Mordenti C; El Hachem M; Chimenti S
    Pediatr Dermatol; 2007; 24(3):332-3. PubMed ID: 17542899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus.
    Rigopoulos D; Baran R; Chiheb S; Daniel CR; Di Chiacchio N; Gregoriou S; Grover C; Haneke E; Iorizzo M; Pasch M; Piraccini BM; Rich P; Richert B; Rompoti N; Rubin AI; Singal A; Starace M; Tosti A; Triantafyllopoulou I; Zaiac M
    J Am Acad Dermatol; 2019 Jul; 81(1):228-240. PubMed ID: 30731172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermoscopic features of nail psoriasis treated with biologics.
    Hashimoto Y; Uyama M; Takada Y; Yoshida K; Ishiko A
    J Dermatol; 2017 May; 44(5):538-541. PubMed ID: 28150346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
    Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
    Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Instability of topical ciclosporin emulsion for nail psoriasis.
    Prins AM; Vos K; Franssen EJ
    Dermatology; 2007; 215(4):362-3. PubMed ID: 17911999
    [No Abstract]   [Full Text] [Related]  

  • 19. Biologic agents in nail psoriasis: efficacy data and considerations.
    Kyriakou A; Patsatsi A; Sotiriadis D
    Expert Opin Biol Ther; 2013 Dec; 13(12):1707-14. PubMed ID: 24156504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is ustekinumab effective for psoriatic arthritis with insufficient response to initial treatment?
    Venegas-Iribarren S; Andino-Navarrete R
    Medwave; 2018 Mar; 18(2):e7174. PubMed ID: 29522505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.